Literature DB >> 8551619

The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains.

U Schubert1, S Bour, A V Ferrer-Montiel, M Montal, F Maldarell, K Strebel.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) Vpu protein is an integral membrane phosphoprotein that induces CD4 degradation in the endoplasmic reticulum and enhances virus release from the cell surface. CD4 degradation is specific, requires phosphorylation of Vpu, and involves the interaction between Vpu and the CD4 cytoplasmic domain. In contrast, regulation of virus release is less specific and not restricted to HIV-1 and may be mechanistically-distinct from CD4 degradation. We show here that a mutant of Vpu, Vpu35, lacking most of its cytoplasmic domain has residual biological activity for virus release but is unable to induce CD4 degradation. This finding suggests that the N terminus of Vpu encoding the transmembrane (TM) anchor represents an active domain important for the regulation of virus release but not CD4 degradation. To better define the functions of Vpu's TM anchor and cytoplasmic domain, we designed a mutant, VpuRD, containing a scrambled TM sequence with a conserved amino acid composition and alpha-helical structure. The resulting protein was integrated normally into membranes, was able to form homo-oligomers, and exhibited expression levels, protein stability, and subcellular localization similar to those of wild-type Vpu. Moreover, VpuRD was capable of binding to CD4 and to induce CD4 degradation with wild-type efficiency, confirming proper membrane topology and indicating that the alteration of the Vpu TM domain did not interfere with this function of Vpu. However, VpuRD was unable to enhance the release of virus particles from infected or transfected cells, and virus encoding VpuRD had replication characteristics in T cells indistinguishable from those of a Vpu-deficient HIV-1 isolate. Mutation of the phosphorylation sites in VpuRD resulted in a protein which was unable to perform either function of Vpu. The results of our experiments suggest that the two biological activities of Vpu operate via two distinct molecular mechanisms and involve two different structural domains of the Vpu protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551619      PMCID: PMC189883     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Sequences present in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein.

Authors:  R L Willey; A Buckler-White; K Strebel
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein.

Authors:  F Maldarelli; M Y Chen; R L Willey; K Strebel
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

3.  The effect of vpu on HIV-1-induced syncytia formation.

Authors:  X J Yao; S Garzon; F Boisvert; W A Haseltine; E A Cohen
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-02

4.  The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.

Authors:  U Schubert; P Henklein; B Boldyreff; E Wingender; K Strebel; T Porstmann
Journal:  J Mol Biol       Date:  1994-02-11       Impact factor: 5.469

5.  Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4.

Authors:  M E Lenburg; N R Landau
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.

Authors:  M J Vincent; N U Raja; M A Jabbar
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  The cytoplasmic domain of CD4 is sufficient for its down-regulation from the cell surface by human immunodeficiency virus type 1 Nef.

Authors:  S J Anderson; M Lenburg; N R Landau; J V Garcia
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

8.  Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses.

Authors:  H G Göttlinger; T Dorfman; E A Cohen; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

9.  Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments.

Authors:  U Schubert; K Strebel
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 Vpu protein induces degradation of CD4 in vitro: the cytoplasmic domain of CD4 contributes to Vpu sensitivity.

Authors:  M Y Chen; F Maldarelli; M K Karczewski; R L Willey; K Strebel
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  138 in total

1.  Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1.

Authors:  F M Marassi; C Ma; H Gratkowski; S K Straus; K Strebel; M Oblatt-Montal; M Montal; S J Opella
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

2.  vpu transmembrane peptide structure obtained by site-specific fourier transform infrared dichroism and global molecular dynamics searching.

Authors:  A Kukol; I T Arkin
Journal:  Biophys J       Date:  1999-09       Impact factor: 4.033

3.  Viral protein U (Vpu)-mediated enhancement of human immunodeficiency virus type 1 particle release depends on the rate of cellular proliferation.

Authors:  A Deora; L Ratner
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1.

Authors:  Che Ma; Francesca M Marassi; David H Jones; Suzana K Straus; Stephan Bour; Klaus Strebel; Ulrich Schubert; Myrta Oblatt-Montal; Mauricio Montal; Stanley J Opella
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

5.  Mapping the energy surface of transmembrane helix-helix interactions.

Authors:  J Torres; A Kukol; I T Arkin
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

6.  Comparative structural studies of Vpu peptides in phospholipid monolayers by x-ray scattering.

Authors:  Songyan Zheng; Joseph Strzalka; David H Jones; Stanley J Opella; J Kent Blasie
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

7.  Molecular dynamics simulations on the first two helices of Vpu from HIV-1.

Authors:  I Sramala; V Lemaitre; J D Faraldo-Gómez; S Vincent; A Watts; W B Fischer
Journal:  Biophys J       Date:  2003-05       Impact factor: 4.033

8.  Characterisation of near-full length genome sequences of three South African human immunodeficiency virus type 1 subtype C isolates.

Authors:  Gillian M Hunt; Maria A Papathanasopoulos; Glenda E Gray; Caroline T Tiemessen
Journal:  Virus Genes       Date:  2003-01       Impact factor: 2.332

9.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

10.  Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs.

Authors:  Sang Ho Park; Stanley J Opella
Journal:  Protein Sci       Date:  2007-08-31       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.